Biotech innovation stocks are _老虎社区_美港股上老虎

2021-08-26

Biotech innovation stocks are on the limelight and need our consideration whether to accumulate these stocks

ADTX Stock: What Is the Huge Covid-19 News Lifting Aditxt 70% Today?

免责声明：上述内容仅代表发帖人个人观点，不构成本平台的任何投资建议。

精彩评论

我们需要你的真知灼见来填补这片空白

发表看法

{"i18n":{"language":"zh_CN"},"detailType":1,"isChannel":false,"data":{"magic":2,"id":810348229,"tweetId":"810348229","gmtCreate":1629947469061,"gmtModify":1631890082388,"author":{"id":3559098973692807,"idStr":"3559098973692807","authorId":3559098973692807,"authorIdStr":"3559098973692807","name":"Chinleong","avatar":"https://static.tigerbbs.com/6dbcd389c42e41aa06c692b423858c4c","vip":1,"userType":1,"introduction":"","boolIsFan":false,"boolIsHead":false,"crmLevel":7,"crmLevelSwitch":0,"individualDisplayBadges":[],"fanSize":48,"starInvestorFlag":false},"themes":[],"images":[],"coverImages":[],"extraTitle":"","html":"<html><head></head><body><p>Biotech innovation stocks are on the limelight and need our consideration&nbsp;whether to accumulate these stocks</p></body></html>","htmlText":"<html><head></head><body><p>Biotech innovation stocks are on the limelight and need our consideration&nbsp;whether to accumulate these stocks</p></body></html>","text":"Biotech innovation stocks are on the limelight and need our consideration whether to accumulate these stocks","highlighted":1,"essential":1,"paper":1,"likeSize":3,"commentSize":0,"repostSize":0,"favoriteSize":0,"link":"https://laohu8.com/post/810348229","repostId":1124672679,"repostType":4,"repost":{"id":"1124672679","pubTimestamp":1629947119,"share":"https://www.laohu8.com/m/news/1124672679?lang=&edition=full","pubTime":"2021-08-26 11:05","market":"us","language":"en","title":"ADTX Stock: What Is the Huge Covid-19 News Lifting Aditxt 70% Today?","url":"https://stock-news.laohu8.com/highlight/detail?id=1124672679","media":"investorplace","summary":"Today, biotech company Aditxt(NASDAQ:ADTX) is absolutely soaring. Shares of ADTX stock are currently","content":"<p>Today, biotech company&nbsp;<b>Aditxt</b>(NASDAQ:<b><u>ADTX</u></b>) is absolutely soaring. Shares of&nbsp;ADTX stock are currently up more than 70% at the time of writing on extremely heavy volume. Nearly 150 million shares have traded hands, relative to an average daily volume of roughly 225,000 shares.</p>\n<p>Accordingly, investors may not be surprised to learn that there’s a big catalyst driving this volume and interest in ADTX stock. Indeed, as a micro cap stock with a total market capitalization of $50 million after today’s rise, Aditxt is not necessarily a company many investors have heard of. However, this biotech innovation company has made headlines today.</p>\n<p>Let’s dive into the key news that’s taking shares of ADTX stock into the stratosphere today.</p>\n<p>ADTX Soaring on Acquisition News</p>\n<p>Normally, when a company announced an acquisition, the acquirer’s stock price drops. This is typically a result of the premium paid for the target company, as investors attempt to re-price the enterprise values of both parties.</p>\n<p>However, for micro cap companies like Aditxt, sometimes making a big splash can work in favor of investors. Such seems to be the case with Aditxt’srecently announced&nbsp;deal to acquire a biopharmaceutical company specializing in commercializing a Covid-19 antiviral oral therapy.</p>\n<p>Today, Aditxt announced it had signed a letter of intent to acquire a company with an oral treatment for Covid-19. Given where we are with vaccinations, investors are looking for future iterations of treatments for the coronavirus. According to the release, the unnamed target company currently has authorization to sell its treatment under emergency and compassionate use. However, in markets outside of the U.S. and Canada, this company’s oral treatment is operating with full approval.</p>\n<p>Indeed, this announcement is intriguing. Accordingly, investors have begun speculation on exactly who the target could be. For now, it appears investors banking on Aditxt’s pipeline of drugs have a commercialized drug in the pipeline to latch onto. For those concerned that the delta variant, and other potential future variants, will elongate the time horizon for needed treatments, ADTX stock may be one that makes the watch list moving forward.</p>","source":"lsy1606302653667","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>ADTX Stock: What Is the Huge Covid-19 News Lifting Aditxt 70% Today?</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nADTX Stock: What Is the Huge Covid-19 News Lifting Aditxt 70% Today?\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-08-26 11:05 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://investorplace.com/2021/08/adtx-stock-what-is-the-huge-covid-19-news-lifting-aditxt-70-today/><strong>investorplace</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Today, biotech company Aditxt(NASDAQ:ADTX) is absolutely soaring. Shares of ADTX stock are currently up more than 70% at the time of writing on extremely heavy volume. Nearly 150 million shares have ...</p>\n\n<a href=\"https://investorplace.com/2021/08/adtx-stock-what-is-the-huge-covid-19-news-lifting-aditxt-70-today/\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"ADTX":"ADiTx Therapeutics"},"source_url":"https://investorplace.com/2021/08/adtx-stock-what-is-the-huge-covid-19-news-lifting-aditxt-70-today/","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1124672679","content_text":"Today, biotech company Aditxt(NASDAQ:ADTX) is absolutely soaring. Shares of ADTX stock are currently up more than 70% at the time of writing on extremely heavy volume. Nearly 150 million shares have traded hands, relative to an average daily volume of roughly 225,000 shares.\nAccordingly, investors may not be surprised to learn that there’s a big catalyst driving this volume and interest in ADTX stock. Indeed, as a micro cap stock with a total market capitalization of $50 million after today’s rise, Aditxt is not necessarily a company many investors have heard of. However, this biotech innovation company has made headlines today.\nLet’s dive into the key news that’s taking shares of ADTX stock into the stratosphere today.\nADTX Soaring on Acquisition News\nNormally, when a company announced an acquisition, the acquirer’s stock price drops. This is typically a result of the premium paid for the target company, as investors attempt to re-price the enterprise values of both parties.\nHowever, for micro cap companies like Aditxt, sometimes making a big splash can work in favor of investors. Such seems to be the case with Aditxt’srecently announced deal to acquire a biopharmaceutical company specializing in commercializing a Covid-19 antiviral oral therapy.\nToday, Aditxt announced it had signed a letter of intent to acquire a company with an oral treatment for Covid-19. Given where we are with vaccinations, investors are looking for future iterations of treatments for the coronavirus. According to the release, the unnamed target company currently has authorization to sell its treatment under emergency and compassionate use. However, in markets outside of the U.S. and Canada, this company’s oral treatment is operating with full approval.\nIndeed, this announcement is intriguing. Accordingly, investors have begun speculation on exactly who the target could be. For now, it appears investors banking on Aditxt’s pipeline of drugs have a commercialized drug in the pipeline to latch onto. For those concerned that the delta variant, and other potential future variants, will elongate the time horizon for needed treatments, ADTX stock may be one that makes the watch list moving forward.","news_type":1},"isVote":1,"tweetType":1,"viewCount":171,"commentLimit":10,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"symbols":[],"verified":2,"subType":0,"readableState":1,"langContent":"EN","currentLanguage":"EN","warmUpFlag":false,"orderFlag":false,"shareable":true,"causeOfNotShareable":"","featuresForAnalytics":[],"commentAndTweetFlag":false,"andRepostAutoSelectedFlag":false,"upFlag":false,"length":93,"xxTargetLangEnum":"ORIG"},"commentList":[],"isCommentEnd":true,"isTiger":false,"isWeiXinMini":false,"url":"/m/post/810348229"}